OpenVSafe by OpenVAERS
Search V-safe

RKM-10860-12197

2 vaccinations 3 coded responses 13 check-ins 3 free-text entries 3 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
611 / IL
Registered
2021-02-04
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-02-03
    Dose 1 — Moderna
  2. 2021-02-04
    Registered in v-safe
  3. 2021-02-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Redness, Itching · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Adult check-in
  4. 2021-02-04
    Report sent to call center — days 1–6 daily, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  5. 2021-02-05
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pain — Feeling: Fair · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Free text: Pain on leftvside upper body, head through shoulder
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-02-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  7. 2021-02-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  8. 2021-02-24
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-03-03
    Dose 2 — Moderna
  10. 2021-03-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  11. 2021-03-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-03-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-03-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-04-14
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  15. 2021-06-02
    Survey response — 3 months, dose 2
    MedDRA: Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Cancer diagnosis
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-06-02
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  17. 2021-06-14
    Call successful
    Participant prefers to complete VAERS report online
  18. 2021-09-03
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2022-03-06
    Survey response — 12 months, dose 2
    MedDRA: Adverse reaction, Breast cancer stage IV — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Hospitalization
    Free text: Diagnosed breast cancer stage iv. Found with symptoms
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-03-06
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
  21. 2022-03-09
  22. 2022-03-14

Vaccinations

DoseDateManufacturerCo-administered
12021-02-03Moderna
22021-03-03Moderna

Call center

3 call center cases

2 successful · 1 unsuccessful

See the call center timeline

Free text

Release 3 — days 1–6 daily, dose 1

2021-02-05

Systemic reaction (other): Pain on leftvside upper body, head through shoulder

Release 8 — 3 months, dose 2

2021-06-02

Symptoms: Cancer diagnosis

Release 11 — 12 months, dose 2

2022-03-06

Symptoms: Diagnosed breast cancer stage iv. Found with symptoms

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAdverse reaction · · ✓
SDBreast cancer stage IV · · ✓
SDPre-existing disease ✓ ✓ ✓
SROPain ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release